Pediatric Short Bowel Syndrome Medication

1. Guillen B, Atherton NS. Short bowel syndrome. StatPearls [Internet]. 2019 Apr 2. [QxMD MEDLINE Link]. [Full Text].

2. Cole CR, Hansen NI, Higgins RD, Ziegler TR, Stoll BJ. Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months. Pediatrics. 2008 Sep. 122(3):e573-82. [QxMD MEDLINE Link]. [Full Text].

3. Weih S, Kessler M, Fonouni H, Golriz M, Hafezi M, Mehrabi A, et al. Current practice and future perspectives in the treatment of short bowel syndrome in children-a systematic review. Langenbecks Arch Surg. 2011 Nov 22. [QxMD MEDLINE Link].

4. Goday PS. Short bowel syndrome: how short is too short?. Clin Perinatol. 2009 Mar. 36(1):101-10. [QxMD MEDLINE Link].

5. Hukkinen M, Mutanen A, Pakarinen MP. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury. Surgery. 2017 Sep. 162 (3):670-9. [QxMD MEDLINE Link].

6. Norsa L, Artru S, Lambe C, Talbotec C, et al. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: Parenteral nutrition or intestinal transplantation. Clin Nutr. 2019 Apr. 38 (2):926-33. [QxMD MEDLINE Link].

7. Cohran VC, Prozialeck JD, Cole CR. Redefining short bowel syndrome in the 21st century. Pediatr Res. 2017 Apr. 81 (4):540-9. [QxMD MEDLINE Link].

8. Capriati T, Giorgio D, Fusaro F, et al. Pediatric short bowel syndrome: predicting four-year outcome after massive neonatal resection. Eur J Pediatr Surg. 2018 Oct. 28 (5):455-63. [QxMD MEDLINE Link].

9. Pederiva F, Khalil B, Morabito A, Wood SJ. Impact of short bowel syndrome on quality of life and family: the patient's perspective. Eur J Pediatr Surg. 2019 Apr. 29 (2):196-202. [QxMD MEDLINE Link].

10. Zeichner SL, Mongodin EF, Hittle L, Huang SH, Torres C. The bacterial communities of the small intestine and stool in children with short bowel syndrome. PLoS One. 2019. 14 (5):e0215351. [QxMD MEDLINE Link]. [Full Text].

11. Park KT, Nespor C, Kerner J Jr. The use of Omegaven in treating parenteral nutrition-associated liver disease. J Perinatol. 2011 Apr. 31 Suppl 1:S57-60. [QxMD MEDLINE Link].

12. Seres D, Sacks GS, Pedersen CA, et al. Parenteral nutrition safe practices: results of the 2003 American Society for Parenteral and Enteral Nutrition survey. JPEN J Parenter Enteral Nutr. 2006 May-Jun. 30(3):259-65. [QxMD MEDLINE Link].

13. Gattex (teduglutide) [package insert]. Lexington, MA: Shire-NPS Pharmaceutics, Inc. May 2019. Available at [Full Text].

14. Takeda Pharmaceuticals, USA, Inc. U.S. FDA approves GATTEX (teduglutide) for children 1 year of age and older with short bowel syndrome (SBS) [press release]. Available at https://www.takeda.com/en-us/newsroom/news-releases/2019/u.s.-fda-approves-gattex-teduglutide-for-children-1-year-of-age-and-older-with-short-bowel-syndrome-sbs/. May 17, 2019; Accessed: May 21, 2019.

15. Carroll RE, Benedetti E, Schowalter JP, Buchman AL. Management and complications of short bowel syndrome: an updated review. Curr Gastroenterol Rep. 2016 Jul. 18 (7):40. [QxMD MEDLINE Link].

16. Carter BA, Cohran VC, Cole CR, et al. Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr. 2017 Feb. 181:102-11.e5. [QxMD MEDLINE Link]. [Full Text].

17. Guo M, Li Y, Li J. Role of Growth Hormone, Glutamine and Enteral Nutrition in Pediatric Short Bowel Syndrome: A Pilot Follow-Up Study. Eur J Pediatr Surg. 2011 Dec 7. [QxMD MEDLINE Link].

18. Goulet OJ, Revillon Y, Jan D, et al. Neonatal short bowel syndrome. J Pediatr. 1991 Jul. 119(1 ( Pt 1)):18-23. [QxMD MEDLINE Link].

19. Novak B. Long-term teduglutide frees some short bowel patients from parenteral support. Medscape Medical News. January 27, 2014. [Full Text].

20. Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012 May. 5(3):159-71. [QxMD MEDLINE Link].

21. Jeppesen PB, Staun M, Tjellesen L, Mortensen PB. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut. 1998 Dec. 43(6):763-9. [QxMD MEDLINE Link].

22. Greenberg RG, Moran C, Ulshen M, Smith PB, Benjamin DK Jr, Cohen-Wolkowiez M. Outcomes of catheter-associated infections in pediatric patients with short bowel syndrome. J Pediatr Gastroenterol Nutr. 2010 Apr. 50(4):460-2. [QxMD MEDLINE Link]. [Full Text].

23. Chung PH, Wong KK, Wong RM, Tsoi NS, Chan KL, Tam PK. Clinical experience in managing pediatric patients with ultra-short bowel syndrome using omega-3 fatty acid. Eur J Pediatr Surg. 2010 Mar. 20(2):139-42. [QxMD MEDLINE Link].

24. Ascher DP, Shoupe BA, Maybee D, Fischer GW. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase. J Pediatr Surg. 1993 Apr. 28(4):627-9. [QxMD MEDLINE Link].

25. Bernard DK, Shaw MJ. Principles of nutrition therapy for short-bowel syndrome. Nutr Clin Pract. 1993 Aug. 8(4):153-62. [QxMD MEDLINE Link].

26. Bloom SR. Gut hormones in adaptation. Gut. 1987. 28 Suppl:31-5. [QxMD MEDLINE Link].

27. Buchman AL. The clinical management of short bowel syndrome: steps to avoid parenteral nutrition. Nutrition. 1997 Oct. 13(10):907-13. [QxMD MEDLINE Link].

28. Byrne TA, Persinger RL, Young LS, et al. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg. 1995 Sep. 222(3):243-54; discussion 254-5. [QxMD MEDLINE Link].

29. Capron JP, Gineston JL, Herve MA, Braillon A. Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet. 1983 Feb 26. 1(8322):446-7. [QxMD MEDLINE Link].

30. Cole CR, Ziegler TR. Small bowel bacterial overgrowth: a negative factor in gut adaptation in pediatric SBS. Curr Gastroenterol Rep. 2007 Dec. 9(6):456-62. [QxMD MEDLINE Link].

31. Cosnes L, Carbonnel F, Beaugerie L. Functional adaptation after extensive small bowel resection in humans. Eur J Gastroenterol Hepatol. 1994. 6:197.

32. Cummings JH. Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol Suppl. 1984. 93:89-99. [QxMD MEDLINE Link].

33. Dudrick SJ, Latifi R, Fosnocht DE. Management of the short-bowel syndrome. Surg Clin North Am. 1991 Jun. 71(3):625-43. [QxMD MEDLINE Link].

34. Fine H, Levine GM, Shiau YF. Effects of cholecystokinin and secretin on intestinal structure and function. Am J Physiol. 1983 Sep. 245(3):G358-63. [QxMD MEDLINE Link].

35. Fordtran JS, Dietschy JM. Water and electrolyte movement in the intestine. Gastroenterology. 1966 Feb. 50(2):263-85. [QxMD MEDLINE Link].

36. Gazet JC, Kopp J. The surgical significance of the ileocecal junction. Surgery. 1964. 56:565-73.

37. Grant D. Current results of intestinal transplantation. The International Intestinal Transplant Registry. Lancet. 1996 Jun 29. 347(9018):1801-3. [QxMD MEDLINE Link].

38. Grosfeld JL, Rescorla FJ, West KW. Short bowel syndrome in infancy and childhood. Analysis of survival in 60 patients. Am J Surg. 1986 Jan. 151(1):41-6. [QxMD MEDLINE Link].

39. Hays TL, Saavedra JM, Mattis LE. The use of high-fat low-carbohydrate diets for advancement of enteral feedings in children with short bowel syndrome. Top Clin Nutr. 1995. 10(4):35-41.

40. Hofmann AF, Poley JR. Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology. 1972 May. 62(5):918-34. [QxMD MEDLINE Link].

41. Hwang TL, O'Dwyer ST, Smith RJ. Preservation of small bowel mucosa using glutamine enriched parenteral nutrition. Surg Forum. 1986. 37:56-8.

42. Hylander E, Ladefoged K, Jarnum S. Calcium absorption after intestinal resection. The importance of a preserved colon. Scand J Gastroenterol. 1990 Jul. 25(7):705-10. [QxMD MEDLINE Link].

43. Hyman PE, Everett SL, Harada T. Gastric acid hypersecretion in short bowel syndrome in infants: association with extent of resection and enteral feeding. J Pediatr Gastroenterol Nutr. 1986 Mar-Apr. 5(2):191-7. [QxMD MEDLINE Link].

44. Infantino BJ, Mercer DF, Hobson BD, Fischer RT, Gerhardt BK, Grant WJ, et al. Successful Rehabilitation in Pediatric Ultrashort Small Bowel Syndrome. J Pediatr. 2013 Jul 15. [QxMD MEDLINE Link].

45. Jeejeebhoy KN. Therapy of the short-gut syndrome. Lancet. 1983 Jun 25. 1(8339):1427-30. [QxMD MEDLINE Link].

46. Klish WJ, Putnam TC. The short gut. Am J Dis Child. 1981 Nov. 135(11):1056-61. [QxMD MEDLINE Link].

47. Langnas AN, Shaw BW Jr, Antonson DL, et al. Preliminary experience with intestinal transplantation in infants and children. Pediatrics. 1996 Apr. 97(4):443-8. [QxMD MEDLINE Link].

48. Levine GM, Deren JJ, Yezdimir E. Small-bowel resection. Oral intake is the stimulus for hyperplasia. Am J Dig Dis. 1976 Jul. 21(7):542-6. [QxMD MEDLINE Link].

49. Lowry SF, Brennan MF. Abnormal liver function during parenteral nutrition: Relation to infusion excess. J Surg Res. 1979. 26:300-7.

50. Marotta RB, Floch MH. Dietary therapy of steatorrhea. Gastroenterol Clin North Am. 1989 Sep. 18(3):485-512. [QxMD MEDLINE Link].

51. Messing B, Pigot F, Rongier M, et al. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology. 1991 Jun. 100(6):1502-8. [QxMD MEDLINE Link].

52. Nightingale JM, Kamm MA, van der Sijp JR, et al. Disturbed gastric emptying in the short bowel syndrome. Evidence for a 'colonic brake'. Gut. 1993 Sep. 34(9):1171-6. [QxMD MEDLINE Link].

53. Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr. 1996 Aug. 64(2):222-31. [QxMD MEDLINE Link].

54. Parker P, Stroop S, Greene H. A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease. J Pediatr. 1981 Sep. 99(3):360-4. [QxMD MEDLINE Link].

55. Purdum PP 3d, Kirby DF. Short-bowel syndrome: a review of the role of nutrition support. JPEN J Parenter Enteral Nutr. 1991 Jan-Feb. 15(1):93-101. [QxMD MEDLINE Link].

56. Reyes J, Todo S, Bueno J, et al. Intestinal transplantation in children: five-year experience. Transplant Proc. 1996 Oct. 28(5):2755-6. [QxMD MEDLINE Link].

57. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997 Oct. 113(4):1074-81. [QxMD MEDLINE Link].

58. Sheldon GF, Peterson SR, Sanders R. Hepatic dysfunction during hyperalimentation. Arch Surg. 1978 Apr. 113(4):504-8. [QxMD MEDLINE Link].

59. Sial S, Koussayer T, Klein S. Nutritional management of a patient with short-bowel syndrome and large-volume jejunostomy output. Nutrition. 1994 Jan-Feb. 10(1):37-40; discussion 40-1. [QxMD MEDLINE Link].

60. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology. 1996 Sep. 111(3):716-9. [QxMD MEDLINE Link].

61. Thompson JS. Surgical management of short bowel syndrome. Surgery. 1993 Jan. 113(1):4-7. [QxMD MEDLINE Link].

62. Thompson JS, Rikkers LF. Surgical alternatives for the short bowel syndrome. Am J Gastroenterol. 1987 Feb. 82(2):97-106. [QxMD MEDLINE Link].

63. Todo S, Tzakis AG, Abu-Elmagd K, et al. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation. 1992 Feb. 53(2):369-76. [QxMD MEDLINE Link].

64. Treem WR. Short bowel syndrome. Wyllie R, Hyams JS, eds. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. Philadelphia, PA: WB Saunders; 1993. 573-603.

65. Vileisis RA, Inwood RJ, Hunt CE. Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr. 1980 May. 96(5):893-7. [QxMD MEDLINE Link].

66. Woolf GM, Miller C, Kurian R, Jeejeebhoy KN. Diet for patients with a short bowel: high fat or high carbohydrate?. Gastroenterology. 1983 Apr. 84(4):823-8. [QxMD MEDLINE Link].

67. Zahavi I, Shaffer EA, Gall DG. Total parenteral nutrition-associated cholestasis: acute studies in infant and adult rabbits. J Pediatr Gastroenterol Nutr. 1985 Aug. 4(4):622-7. [QxMD MEDLINE Link].

68. Zurier RB, Campbell RG, Hashim SA, Van Itallie TB. Use of medium-chain triglyceride in management of patients with massive resection of the small intestine. N Engl J Med. 1966 Mar 3. 274(9):490-3. [QxMD MEDLINE Link].

69. Marino IR, Lauro A. Surgeon's perspective on short bowel syndrome: Where are we?. World J Transplant. 2018 Oct 22. 8 (6):198-202. [QxMD MEDLINE Link]. [Full Text].

70. Coletta R, Morabito A. Non-transplant surgical management of short bowel syndrome in children: an overview. Curr Pediatr Rev. 2018 Nov 29. [QxMD MEDLINE Link].

71. Norsa L, Lambe C, Abi Abboud S, et al. The colon as an energy salvage organ for children with short bowel syndrome. Am J Clin Nutr. 2019 Apr 1. 109 (4):1112-8. [QxMD MEDLINE Link].

Carmen Cuffari, MD Associate Professor, Department of Pediatrics, Division of Gastroenterology/Nutrition, Johns Hopkins University School of Medicine

Carmen Cuffari, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, Royal College of Physicians and Surgeons of Canada

Disclosure: Received honoraria from Prometheus Laboratories for speaking and teaching; Received honoraria from Abbott Nutritionals for speaking and teaching. for: Abbott Nutritional, Abbvie, speakers' bureau.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

David A Piccoli, MD Chief of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia; Professor, University of Pennsylvania School of Medicine

David A Piccoli, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Disclosure: Nothing to disclose.

Jatinder Bhatia, MBBS, FAAP Professor of Pediatrics, Medical College of Georgia, Georgia Regents University; Chief, Division of Neonatology, Director, Fellowship Program in Neonatal-Perinatal Medicine, Director, Transport/ECMO/Nutrition, Vice Chair, Clinical Research, Department of Pediatrics, Children's Hospital of Georgia

Jatinder Bhatia, MBBS, FAAP is a member of the following medical societies: Academy of Nutrition and Dietetics, American Academy of Pediatrics, American Association for the Advancement of Science, American Pediatric Society, American Society for Nutrition, American Society for Parenteral and Enteral Nutrition, Society for Pediatric Research, Southern Society for Pediatric Research

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Nestle<br/>Serve(d) as a speaker or a member of a speakers bureau for: Nestle<br/>Received income in an amount equal to or greater than $250 from: Nestle.

Jorge H Vargas, MD Professor of Pediatrics and Clinical Professor of Pediatric Gastroenterology, University of California, Los Angeles, David Geffen School of Medicine; Consulting Physician, Department of Pediatrics, University of California at Los Angeles Health System

Jorge H Vargas, MD is a member of the following medical societies: American Liver Foundation, Latin American Society of Pediatric Gastroenterology, Hepatology & Nutrition, American Society for Gastrointestinal Endoscopy, American Society for Parenteral and Enteral Nutrition, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article